Tamsyn Meyer
Tamsyn is the lead of the study team. She has helped organize our concluded and running investigator-initiated trials (IIT) including pyoderma gangrenosum and canakinumab, chronic urticarial and canakinumab, as well as a new multicentric IIT for scalp psoriasis that will start very soon.